1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Clobetasol propionate |
| brand | String | Temovate, Clobex, Cormax, Olux, Olux-E, Impoyz |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Corticosteroids|Corticosteroid]] • [[:Category:Glucocorticoids|Glucocorticoid]] • [[:Category:Topical_corticosteroids|Topical corticosteroid (Class I • super-potent)]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-0000079C-QINU`"', '"`UNIQ--vote-0000079D-QINU`"' |
| starting_dose | String | Apply a thin film to affected area BID; '''limit to 2 weeks''' continuous use and ≤50 g/week (cream/ointment); ≤50 mL/week (foam/solution); avoid face, intertriginous areas |
| preparations | String | Cream, ointment, lotion, foam, solution, shampoo, spray at 0.025-0.05%; emollient and non-emollient bases |
| fda_max | String | 50 g/week (cream/ointment); 2-week continuous limit; 4-week maximum cumulative |
| pill_id | Text | |
| routes | List of String, delimiter: , | Topical |
| onset | String | Hours to days for inflammation; substantial improvement within 1 week |
| duration | String | Hours to days per application |
| halflife | String | Not meaningfully described for topical use (systemic exposure varies with surface area, occlusion, skin integrity)'"`UNIQ--ref-0000079E-QINU`"' |
| bioavailability | String | Topical with variable systemic absorption depending on body site, occlusion, and skin integrity; HPA-axis suppression is documented even with brief courses to large areas'"`UNIQ--ref-0000079F-QINU`"' |
| pregnancy | String | Topical corticosteroids in pregnancy: use lowest potency and smallest area; super-potent agents like clobetasol are reserved for compelling indications.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |
